Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
<p>Abstract</p> <p>Although some patients are initially sensitive to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), resistance invariably develops. Therefore, it’s very important to study the molecular mechanism of this resistance. In our previous study we...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://www.cancerci.com/content/13/1/15 |